The independent source for health policy research, polling, and news.
KFF’s policy research provides facts and analysis on a wide range of policy issues and public programs.
KFF designs, conducts and analyzes original public opinion and survey research on Americans’ attitudes, knowledge, and experiences with the health care system to help amplify the public’s voice in major national debates.
KFF Health News is a national newsroom that produces in-depth journalism about health issues and is one of the organization’s core operating programs.
This report provides an analysis of donor government funding to address the HIV response in low- and middle-income countries in 2021, the latest year available, as well as trends over time. It includes both bilateral funding from donors and their multilateral contributions to the Global Fund to Fight AIDS, Tuberculosis and Malaria (Global Fund), UNITAID, and Joint United Nations Programme on HIV/AIDS (UNAIDS).
As Congress again considers increased assistance for the global response to COVID-19, we look at how current U.S. global COVID-19 emergency funding is being channeled, particularly to countries and regions.
This analysis assesses the association between PEPFAR investments and maternal and child health outcomes. It finds that the program was associated with significant, positive improvement maternal and child health, adding to the evidence base that PEPFAR has had positive health spillover effects beyond just HIV.
In 2020, only 25% of people who could benefit from pre-exposure prophylaxis (PrEP), a medication that reduces the risk of acquiring HIV, were prescribed it. Using telehealth to provide PrEP, “tele-PrEP,” is a new approach that shows potential for expanding access to PrEP use in the United States that predates the COVID-19 pandemic.
This Vaccine Monitor survey shows the public is largely supportive of the U.S. role in distributing COVID-19 vaccines globally, as well as other response efforts including the distribution of masks and COVID-19 rapid tests.
With funding for additional COVID-19 support at a stalemate in Congress, a new KFF analysis looks at potential scenarios that United States might face if a 4th COVID-19 vaccine dose is recommended to the public.
This Data Note estimates how far the current U.S. supply of COVID-19 vaccines could stretch under different vaccination and booster scenarios. While estimated U.S. COVID-19 vaccine supply needs vary widely depending on assumptions and how many people choose to get vaccinated, this analysis indicates that under a plausible set of scenarios where 4th doses are recommended, the federal government is unlikely to have enough doses already purchased to cover the U.S. population.
This analysis looks at the amount of funding for vaccines and the number of vaccine doses that have been donated to the global COVID-19 vaccine effort and standardizes these donations based on the size of donor economies.
The COVID-19 has exacted a significant toll on the global economy. This new analysis looks at the economic impacts in PEPFAR countries finding that these countries generally fared worse than their economic and regional peers. In addition, the projected economic growth in these countries remains below pre-pandemic levels.
This piece provides an analysis of COVID-19 vaccination rates among 5-11 year-old children across the states. Overall, we find wide variation in share of children who have received at least one dose of a COVID-19 vaccine across the states.
© 2025 KFF